Structure Therapeutics annual ebitda
2022
2023
2024
2025
Structure Therapeutics EBITDA Growth & History (GPCR)
Structure Therapeutics's calculated EBITDA was −$175.2M for fiscal 2025.
View full Structure Therapeutics company overviewStructure Therapeutics annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$175.2M | −$18.0M | — |
| 2024 | 2024-12-31 | −$157.2M | −$54.8M | — |
| 2023 | 2023-12-31 | −$102.5M | −$50.2M | — |
| 2022 | 2022-12-31 | −$52.3M | — | — |
Structure Therapeutics quarterly ebitda
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$118.1M | −$47.9M | — |
| Q1 2026 | 2026-03-31 | −$88.8M | −$32.8M | — |
| Q4 2025 | 2025-12-31 | $24.4M | $71.2M | — |
| Q3 2025 | 2025-09-30 | −$73.4M | −$27.9M | — |
| Q2 2025 | 2025-06-30 | −$70.2M | −$37.1M | — |
| Q1 2025 | 2025-03-31 | −$56.0M | −$24.2M | — |
| Q4 2024 | 2024-12-31 | −$46.8M | −$15.9M | — |
| Q3 2024 | 2024-09-30 | −$45.6M | −$19.5M | — |
| Q2 2024 | 2024-06-30 | −$33.1M | −$7.2M | — |
| Q1 2024 | 2024-03-31 | −$31.8M | −$12.2M | — |
| Q4 2023 | 2023-12-31 | −$30.9M | −$18.0M | — |
| Q3 2023 | 2023-09-30 | −$26.1M | −$13.4M | — |
| Q2 2023 | 2023-06-30 | −$25.9M | −$12.0M | — |
| Q1 2023 | 2023-03-31 | −$19.6M | −$6.7M | — |
| Q4 2022 | 2022-12-31 | −$12.9M | — | — |
| Q3 2022 | 2022-09-30 | −$12.6M | — | — |
| Q2 2022 | 2022-06-30 | −$13.9M | — | — |
| Q1 2022 | 2022-03-31 | −$12.9M | — | — |
Structure Therapeutics ebitda trends
Between the periods ended 2022-12-31 and 2025-12-31, Structure Therapeutics's ebitda decreased from −$52.3M to −$175.2M, a change of −$122.9M. The latest reported quarter, Q2 2026, shows −$118.1M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Structure Therapeutics source filings ↗Community posts
Structure reports up to 16.2% weight loss in extended obesity study
Structure Therapeutics ($GPCR) reported up to 16.2% average body-weight reduction at 72 weeks in an open-label extension study of aleniglipron, its experimental oral GLP-1 treatment. Participants in the highest-performing group had escalate ...